V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009212 | 280006466 | 1.8 | 86 | Palliative (P) | 2016-02-20 | 2016-03-01 | NIVOLUMAB | 02 | N | 280030330 | DACARBAZINE |
| 280009213 | 280010770 | 1.7 | null | null | null | 2015-09-30 | BCG Intravesical | 02 | Y | 280030332 | EVEROLIMUS |
| 280009214 | 280011783 | 1.78 | 84.5 | Curative (C) | 2016-05-22 | 2016-07-24 | STS Rhabdo VIT0910 Vinc Irinotecan | N | N | 280030339 | BUSULFAN + MELPHALAN |
| 280009216 | 280006469 | 1.76 | 77 | Palliative (P) | 2015-06-20 | 2015-07-01 | VINCRISTINE | N | N | 280030346 | LIPOSOMAL DOXORUBICIN |
| 280009217 | 280006470 | 1.63 | 83.95 | Curative (C) | 2017-08-09 | 2017-08-09 | Dox + HD Mtx (post PAM) | 02 | N | 280030348 | NIVOLUMAB |
| 280009218 | 280006470 | 1.7 | null | Palliative (P) | 2017-11-11 | 2017-11-11 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280030348 | TRASTUZUMAB |
| 280009219 | 280006471 | null | 79.8 | Palliative (P) | 2018-05-03 | 2018-05-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 280030355 | TRASTUZUMAB |
| 280009220 | 280006472 | null | null | Palliative (P) | 2016-06-10 | 2016-07-19 | Carbo F | 2 | N | 280030355 | VIDE |
| 280009221 | 280006473 | 1.55 | 61.9 | Curative (C) | 2017-05-10 | 2017-05-22 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 280030360 | CETUXIMAB + IRINOTECAN + MDG |
| 280009222 | 280006476 | 1.56 | 61.5 | Palliative (P) | null | 2018-02-20 | LIPOSOMAL DOXORUBICIN | N | N | 280030371 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009223 | 280010772 | 1.78 | 66.4 | Palliative (P) | 2013-04-26 | 2013-05-08 | NIVOLUMAB | N | N | 280030372 | CETUXIMAB + IRINOTECAN + MDG |
| 280009224 | 280006477 | null | 79.8 | Neo-adjuvant (N) | 2017-10-24 | 2018-02-09 | Cisplatin + Doxorubicin | Y | N | 280030373 | BENDAMUSTINE + RITUXIMAB |
| 280009225 | 280006481 | 1.81 | 19.1 | Palliative (P) | 2016-09-11 | 2016-09-20 | Cyclophosphamide + Vincristine | N | N | 280030373 | BCG |
| 280009226 | 280006482 | 1.55 | 54.8 | null | 2015-04-18 | 2015-04-21 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280030383 | CARBOPLATIN + CETUXIMAB + FU |
| 280009227 | 280006483 | 1.84 | 96 | null | 2013-10-22 | 2013-10-22 | Capecitabine + Streptozocin | 2 | N | 280030383 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009228 | 280006484 | null | 55 | null | 2014-01-15 | 2014-01-17 | Docetaxel | 02 | Y | 280030386 | BCG |
| 280009229 | 280006484 | 1.7 | 92 | Palliative (P) | 2017-11-28 | 2017-12-11 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 280030386 | VINORELBINE |
| 280009230 | 280006487 | 1.65 | 78 | Palliative (P) | 2018-01-14 | 2018-01-26 | Cetuximab + CISPLATIN + FLUOROURACIL | 01 | N | 280030387 | DAIICHI TRIAL |
| 280009231 | 280006487 | 1.53 | 101.7 | Palliative (P) | 2017-09-06 | 2017-10-09 | Capecitabine | N | N | 280030387 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280009232 | 280011784 | 1.59 | 82.8 | null | 2013-11-13 | 2014-04-11 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 280030399 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009233 | 280006488 | null | 67.4 | Palliative (P) | 2018-10-10 | 2019-02-23 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280030403 | COMPARE TRIAL |
| 280009234 | 280006489 | 1.67 | 72.4 | null | 2013-03-08 | 2013-03-11 | Capecitabine + Oxaliplatin 14day | 02 | N | 280030403 | REGORAFENIB |
| 280009235 | 280010776 | 1.62 | 90 | Palliative (P) | 2016-09-21 | 2016-09-22 | CREATE TRIAL | 02 | N | 280030412 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009236 | 280006490 | 1.9 | 11.1 | null | 2017-06-10 | 2017-06-13 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280030413 | METHOTREXATE HIGH DOSE |
| 280009237 | 280006491 | null | null | Palliative (P) | 2015-07-31 | 2015-08-01 | Etoposide IV | null | null | 280030417 | EPSSG |
| 280009238 | 280006492 | 1.78 | 87.1 | Palliative (P) | 2015-05-02 | 2015-05-13 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | 280030421 | CISPLATIN + FLUOROURACIL + RT |
| 280009240 | 280006494 | null | 83.95 | Curative (C) | null | 2013-07-08 | PERTUZUMAB + TRASTUZUMAB | null | null | 280030432 | VIDE |
| 280009241 | 280006495 | null | null | Palliative (P) | 2015-06-28 | 2015-06-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 280030436 | CARBO + FLUOROURACIL |
| 280009242 | 280006496 | 0 | null | Curative (C) | 2017-06-27 | 2017-08-15 | Cyclophosphamide PO +Vinorelbine IV | 2 | N | 280030448 | DACARBAZINE |
| 280009243 | 280006497 | 1.78 | 77.3 | Palliative (P) | 2016-10-16 | 2016-12-01 | DABRAFENIB | N | N | 280030450 | BENDAMUSTINE + RITUXIMAB |
| 280009244 | 280006500 | null | 68.9 | Palliative (P) | 2014-06-10 | 2015-04-21 | VIDE | N | Y | 280030454 | BUSULFAN + MELPHALAN |
| 280009245 | 280006501 | 1.77 | 67.5 | Palliative (P) | null | 2016-02-22 | CMV | N | N | 280030458 | BUSULFAN + MELPHALAN |
| 280009246 | 280006502 | null | 78 | Palliative (P) | 2015-12-12 | 2015-12-12 | IVADo | N | N | 280030464 | LIPOSOMAL DOXORUBICIN |
| 280009247 | 280010777 | null | 77 | Palliative (P) | null | 2017-08-20 | VIDE | N | N | 280030466 | TIMELY TRIAL |
| 280009248 | 280006504 | 1.81 | 92 | Palliative (P) | 2016-01-01 | 2016-01-01 | IVADo | N | null | 280030468 | IFOSFAMIDE + VINCRISTINE |
| 280009249 | 280006506 | 1.72 | 71.1 | Palliative (P) | 2017-10-17 | 2017-10-17 | Cetuximab + CISPLATIN + FLUOROURACIL | N | null | 280030478 | PAZOPANIB |
| 280009250 | 280006507 | null | 70.2 | null | null | 2013-06-18 | Carboplatin + Cetux + FU (Cycle 1) | null | null | 280030483 | CARBOPLATIN + CETUXIMAB + FU |
| 280009251 | 280009392 | 1.74 | 92.8 | Palliative (P) | 2014-11-29 | 2015-04-06 | Folfirinox | N | null | 280030483 | CARBO + FLUOROURACIL |
| 280009252 | 280009392 | 1.6 | null | Palliative (P) | 2016-09-14 | 2017-03-21 | IPM | 2 | N | 280030483 | CISPLATIN + FLUOROURACIL + RT |
| 280009253 | 280011951 | 1.81 | 167 | Disease modification (D) | 2016-04-03 | 2016-05-01 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | Y | 280030489 | CARBOPLATIN + CETUXIMAB + FU |
| 280009254 | 280012085 | 1.83 | 69 | Palliative (P) | 2017-02-08 | 2017-07-17 | Rituximab | 02 | N | 280030502 | VINORELBINE |
| 280009255 | 280012085 | 1.73 | 70 | Palliative (P) | 2018-06-12 | 2019-02-20 | EOX | 02 | N | 280030502 | CARBO + FLUOROURACIL |
| 280009256 | 280006512 | 1.8 | 9.2 | Palliative (P) | 2016-09-14 | 2016-09-21 | Cisplatin + Doxorubicin | N | N | 280030508 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280009257 | 280006514 | 1.66 | null | Palliative (P) | 2016-08-28 | 2016-09-24 | Doxorubicin + Gemcitabine | N | Y | 280030509 | METHOTREXATE HIGH DOSE |
| 280009258 | 280006518 | 1.61 | 67.4 | Curative (C) | 2013-04-26 | 2013-05-29 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280030511 | CAPECITABINE |
| 280009259 | 280006518 | 168 | null | null | 2017-11-09 | 2017-11-09 | CYCLOPHOSPHAMIDE + VINORELBINE | null | null | 280030511 | CAPECITABINE + CISPLATIN |
| 280009260 | 280006520 | 1.7 | 88.2 | null | null | 2014-12-04 | GEDDIS TRIAL | null | null | 280030516 | SUNITINIB |
| 280009261 | 280006521 | null | 65.5 | Palliative (P) | 2014-02-21 | 2014-03-10 | Pazopanib | Y | N | 280030517 | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN |
| 280009262 | 280006522 | 1.62 | null | null | 2014-05-03 | 2014-11-08 | Bendamustine+Rituximab(Sub Courses) | N | null | 280030522 | VIA |
| 280009263 | 280009397 | 0 | 82.7 | Palliative (P) | 2014-08-19 | 2014-09-21 | Cyclophosphamide + Vincristine | N | N | 280030524 | CISPLATIN + FLUOROURACIL + RT |